BeOne Medicines Ltd ADR [ONC] stock prices are up 5.38% to $276.53 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ONC shares have gain 7.60% over the last week, with a monthly amount glided 23.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
BeOne Medicines Ltd ADR [NASDAQ: ONC] stock has seen the most recent analyst activity on April 07, 2025, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $312. Previously, BofA Securities upgraded its rating to Buy on March 03, 2025, and elevated its price target to $320. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $288 on September 18, 2024. Macquarie started tracking with a Outperform rating for this stock on September 12, 2023, and assigned it a price target of $259. In a note dated August 17, 2023, Jefferies initiated an Buy rating and provided a target price of $287 on this stock.
The stock price of BeOne Medicines Ltd ADR [ONC] has been fluctuating between $141.31 and $287.88 over the past year. Currently, Wall Street analysts expect the stock to reach $303.5 within the next 12 months. BeOne Medicines Ltd ADR [NASDAQ: ONC] shares were valued at $276.53 at the most recent close of the market. An investor can expect a potential return of 9.75% based on the average ONC price forecast.
Analyzing the ONC fundamentals
The BeOne Medicines Ltd ADR [NASDAQ:ONC] reported sales of 4.18B for trailing twelve months, representing a surge of 48.64%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.12 and Total Capital is -0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that BeOne Medicines Ltd ADR [NASDAQ:ONC]’s Current Ratio is 1.96. Also, the Quick Ratio is 1.71, while the Cash Ratio stands at 1.27. Considering the valuation of this stock, the price to sales ratio is 7.26, the price to book ratio is 8.53.
Transactions by insiders
Recent insider trading involved Ball Titus B., Principal Accounting Officer, that happened on Jun 11 ’25 when 134.0 shares were sold. Chair, Scientific Advisory Brd, Wang Xiaodong completed a deal on Jun 10 ’25 to sell 41760.0 shares. Meanwhile, Officer TITUS BENJAMIN BALL bought 134.0 shares on Jun 11 ’25.
